Acting sooner means reducing risks for heart disease, diabetes, and liver problems now.
Patients should be reassured that isolated episodes of green stools, in the absence of other worrying symptoms, rarely signify serious pathology
In May 2025, CheqUp, based in the UK, and WeightWatchers teamed up to offer clinical GLP-1 medication support along with behavioral lifestyle programs
In addition to their impressive impact on weight, GLP-1 agonists also provide valuable health advantages, including better blood sugar control for those living with type 2 diabetes and a lowered risk of cardiovascular disease
The research is the first to examine a potential association between suicidal ideation and semaglutide
With ongoing support, weight loss often follows shortly after